Insiders · Profile

Young Matthew P.

EVP & CFO at Jazz Pharmaceuticals. Filing since 16 Jan 2018. CIK 0001601583

Company
Date
Role
Action
Shares
Amount
Of holding
6 Mar 2019
EVP & CFO
Sold, plan not stated
1,152
$155.99K
3.1%
27 Feb 2019
EVP & CFO
Sold, plan not stated
884
$121.91K
3.1%
26 Feb 2019
EVP & CFO
Sold, plan not stated
1,032
$129.96K
3.3%
23 Nov 2018
EVP & CFO
Sold, plan not stated
700
$105.00K
2.1%
15 Oct 2018
EVP & CFO
Sold, plan not stated
700
$110.66K
2.1%
17 Sep 2018
EVP & CFO
Sold, plan not stated
700
$113.89K
2.0%
15 Aug 2018
EVP & CFO
Sold, plan not stated
700
$123.24K
2.0%
16 Jul 2018
EVP & CFO
Sold, plan not stated
700
$123.24K
2.0%
15 Jun 2018
EVP & CFO
Sold, plan not stated
700
$123.89K
1.9%
1 Jun 2018
EVP & CFO
Sold, plan not stated
5,000
$850.21K
12.1%
15 May 2018
EVP & CFO
Sold, plan not stated
1,420
$233.79K
3.8%
16 Apr 2018
EVP & CFO
Sold, plan not stated
700
$109.21K
1.8%
15 Mar 2018
EVP & CFO
Sold, plan not stated
700
$105.85K
1.8%
6 Mar 2018
EVP & CFO
Sold, plan not stated
1,152
$164.00K
2.8%
28 Feb 2018
EVP & CFO
Sold, plan not stated
1,219
$181.41K
3.6%
27 Feb 2018
EVP & CFO
Sold, plan not stated
1,916
$278.97K
5.2%
16 Jan 2018
EVP & CFO
Sold, plan not stated
700
$106.51K
1.8%
17 decisions on file.